NO995822L - Sulfatsalt av en HIV-proteaseinhibitor som har forbedret oral absorpsjon og biotilgjengelighet - Google Patents

Sulfatsalt av en HIV-proteaseinhibitor som har forbedret oral absorpsjon og biotilgjengelighet

Info

Publication number
NO995822L
NO995822L NO995822A NO995822A NO995822L NO 995822 L NO995822 L NO 995822L NO 995822 A NO995822 A NO 995822A NO 995822 A NO995822 A NO 995822A NO 995822 L NO995822 L NO 995822L
Authority
NO
Norway
Prior art keywords
protease inhibitor
sulfate salt
hiv protease
bioavailability
oral absorption
Prior art date
Application number
NO995822A
Other languages
English (en)
Norwegian (no)
Other versions
NO995822D0 (no
Inventor
David Askin
R Scott Hoerrner
Robert M Purick
Paul Reider
Richard J Varsolona
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9714320.0A external-priority patent/GB9714320D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO995822D0 publication Critical patent/NO995822D0/no
Publication of NO995822L publication Critical patent/NO995822L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995822A 1997-05-29 1999-11-26 Sulfatsalt av en HIV-proteaseinhibitor som har forbedret oral absorpsjon og biotilgjengelighet NO995822L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4795097P 1997-05-29 1997-05-29
GBGB9714320.0A GB9714320D0 (en) 1997-07-07 1997-07-07 Hiv protease inhibitor
PCT/US1998/010633 WO1998054178A1 (en) 1997-05-29 1998-05-26 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability

Publications (2)

Publication Number Publication Date
NO995822D0 NO995822D0 (no) 1999-11-26
NO995822L true NO995822L (no) 2000-01-28

Family

ID=26311845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995822A NO995822L (no) 1997-05-29 1999-11-26 Sulfatsalt av en HIV-proteaseinhibitor som har forbedret oral absorpsjon og biotilgjengelighet

Country Status (22)

Country Link
EP (1) EP0986554A1 (pt)
JP (1) JP3267632B2 (pt)
KR (1) KR20010013042A (pt)
CN (1) CN1257497A (pt)
AU (1) AU730245B2 (pt)
BG (1) BG103923A (pt)
BR (1) BR9809498A (pt)
CA (1) CA2291086A1 (pt)
EA (1) EA199901095A1 (pt)
EE (1) EE9900543A (pt)
HR (1) HRP980283A2 (pt)
HU (1) HUP0004621A3 (pt)
ID (1) ID23858A (pt)
IL (1) IL132779A0 (pt)
IS (1) IS5240A (pt)
NO (1) NO995822L (pt)
PE (1) PE75099A1 (pt)
PL (1) PL336847A1 (pt)
SK (1) SK163299A3 (pt)
TR (1) TR199902816T2 (pt)
TW (1) TW438799B (pt)
WO (1) WO1998054178A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514910A (ja) * 1999-11-24 2003-04-22 メルク エンド カムパニー インコーポレーテッド Hivプロテアーゼ阻害剤としてのガンマ−ヒドロキシ−2−(フルオロアルキルアミノカルボニル)−1−ピペラジンペンタンアミド類
WO2002022582A2 (en) * 2000-09-14 2002-03-21 Ortho-Mcneil Pharmaceutical, Inc. Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ278201A (en) * 1993-12-15 1998-01-26 Merck & Co Inc Bicyclic heterocyclically substituted piperazine derivatives as hiv protease inhibitors

Also Published As

Publication number Publication date
WO1998054178A1 (en) 1998-12-03
KR20010013042A (ko) 2001-02-26
BG103923A (en) 2000-06-30
HRP980283A2 (en) 1999-08-31
IL132779A0 (en) 2001-03-19
NO995822D0 (no) 1999-11-26
HUP0004621A2 (hu) 2002-03-28
SK163299A3 (en) 2000-07-11
AU7595998A (en) 1998-12-30
EE9900543A (et) 2000-06-15
EA199901095A1 (ru) 2000-08-28
PL336847A1 (en) 2000-07-17
CN1257497A (zh) 2000-06-21
TW438799B (en) 2001-06-07
BR9809498A (pt) 2000-06-20
ID23858A (id) 2000-05-25
CA2291086A1 (en) 1998-12-03
TR199902816T2 (xx) 2000-02-21
PE75099A1 (es) 1999-08-11
EP0986554A1 (en) 2000-03-22
JP2000513747A (ja) 2000-10-17
HUP0004621A3 (en) 2002-04-29
IS5240A (is) 1999-11-09
JP3267632B2 (ja) 2002-03-18
AU730245B2 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
NO20052907L (no) Sykloalkylendikarboksylsyreforbindelser som antiinflammatoriske, immunmodulatoriske og antiproliferative midler
NO2014011I1 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
NO941677D0 (no) Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel
MXPA03000706A (es) Acido sulfonilaminoetilbenzoico substituido (derivado) y su preparacion.
DK1392642T3 (da) Hidtil ukendte forbindelser som anti-inflammatoriske, immunmodulatoriske og antiproliferative midler
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
DE60009511D1 (de) Nematizide trifluorbutene
DE69131317D1 (de) HIV-Proteaseinhibitoren
ATE369857T1 (de) Methode zur stabilisierung von benzimidazol- verbindungen
EA200301276A1 (ru) Новые производные сульфоновых кислот
DK1476470T3 (da) Stivelsesderivater, stivelse-aktivstof-konjugater, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemidler
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
EA200400214A1 (ru) Азитромицин в виде разовой дозы
DK0682947T3 (da) Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
NO995822L (no) Sulfatsalt av en HIV-proteaseinhibitor som har forbedret oral absorpsjon og biotilgjengelighet
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DK0388873T3 (da) Herbicide (((1,3,5-triazin-2-yl)aminocarbonyl)aminosulfonyl)benzoesyreestere, fremgangsmåde til deres fremstilling og deres anvendelse
DK396288A (da) Vandige oploesninger af doxorubicin, hydrochlorid
FI962435A (fi) N.N'-bis(2-hydroksibentsyyli)eteenidiamiini-N,N'-dietikkahapon johdannaiset kelatoivina aineina
DE50100102D1 (de) Verfahren zur Herstellung von Phosphoniumsalzen
DE60111634D1 (de) Verfahren zur herstellung von thiazolidinedion-derivaten und zwischenprodukte
DK1413575T3 (da) Fremgangsmåde til fremstilling af derivater af (1,5-diaryl)pyrazol-3-ylpropansyre
NO20041878L (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application